Drug therapy for patients with stable heart failure can
be simplified by stopping diuretics, according to late breaking results
from the ReBIC-1 trial presented at Heart Failure 2019, a scientific congress
of the European Society of Cardiology (ESC). The trial was conducted by the
Brazilian Research Network in Heart Failure (ReBIC), which includes 11 tertiary
care university hospitals in Brazil.
The eligibility criteria included no or mild symptoms
(defined as New York Heart Association functional class I to II), reduced left
ventricular ejection fraction (45% or below), no heart failure-related hospital
admission within the last six months, and receiving low-dose furosemide (40 to
80 mg per day) for at least six months.
A total of 188 outpatients with stable chronic heart
failure were randomly allocated to maintain or withdraw (placebo) the diuretic
furosemide. The two primary outcomes were:
·
Patient reported dyspnoea using a visual analogue scale
at four time points across 90 days
·
Proportion of patients maintained without additional
diuretics during the 90-day follow-up (on top of the randomly allocated
diuretic or placebo)
There was no difference between groups in the
self-perception of dyspnoea during the 90-day follow-up period. Also, 72
patients (75.3%) in the withdrawal group and 78 patients (83.9%) in the
maintenance group were free of furosemide reuse during follow-up (p=0.16).
According to Dr Andréia Biolo, of the Federal University
of Rio Grande do Sul and Senior author of the study, patients with stable heart
failure who stop diuretics do not have more dyspnoea than those who continue
taking the drug. Withdrawal also does not lead to increased reuse of diuretics
– around 20% of patients in both groups needed a top-up, presumably for symptom
relief.”
(Source: ESC)
Dr KK Aggarwal
Padma Shri
Awardee
President Elect Confederation of
Medical Associations in Asia and Oceania
(CMAAO)
Group Editor-in-Chief
IJCP Publications
President Heart
Care Foundation of India
Past National President
IMA
No comments:
Post a Comment